REDUCTION IN FISTULA IN INFLIXIMAB TREATED PATIENTS
Wallace Crandall, Robert N. Baldassano(Children's Hospital of Philadelphia), Julie Livingston(New York University), Jeffrey Hyams(Herlev Hospital), James Markowitz, George D. Ferry(Baylor College of Medicine), Subra Kugathasan(Children's Healthcare of Atlanta), Anne Griffiths(Medical College of Wisconsin), Stanley A. Cohen(Troy Gastroenterology), Harland S. Winter(Massachusetts General Hospital), Grace Liu, Allan Olson, G. Veereman‐Wauters(Semmelweis University), Robert Heuschkel(European CanCer Organisation)
Journal of Pediatric Gastroenterology and Nutrition
October 1, 2006
Cited by 0
Related Papers
Human gut microbiome viewed across age and geography
|Nature|2012|7.9k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k